Stefanie M Thomas1,2, Jemily Malvar1, Hanh Henry Tran3, Jared T Shows4, David R Freyer1,2,5. 1. Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California. 2. Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California. 3. Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. 4. Department of Pathology, Long Beach Memorial/Miller Children's Hospital, Long Beach, California. 5. Department of Medicine and University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
Abstract
BACKGROUND: Low cancer clinical trial (CCT) enrollment may contribute to survival disparities affecting adolescents and young adults (AYAs) (ages 15-39 years). The objective of this study was to evaluate whether differences in CCT availability related to treatment site could explain the low CCT enrollment. METHODS: This prospective, observational cohort study was conducted at an academic children's hospital and its affiliated but geographically separated adult cancer hospital within a National Cancer Institute-designated Comprehensive Cancer Center. For consecutive, newly diagnosed AYA patients, it was determined whether an appropriate CCT existed nationally, was available at the treatment site, and was used for enrollment. Proportions of AYAs in these categories were compared between sites using the chi-square test. RESULTS: One hundred fifty-two consecutive AYA patients were included from the children's hospital (n = 68; ages 15-20 years) and the adult cancer hospital (n = 84; ages 18-39 years). Although there was no difference in CCT existence for individual AYA patients by site (children's hospital [36 of 68 patients; 52.9%] vs adult cancer hospital [45 of 84 patients; 53.6%]; P = .938), CCT availability was significantly lower at the adult cancer hospital (14 of 84 patients [16.7%] vs 30 of 68 [44.1%] at the children's hospital; P < .001). The proportion of AYAs enrolled was low at both sites (8 of 68 patients [11.8%] vs 6 of 84 patients [7.1%], respectively; P = .327). Fewer existing CCTs were available at the adult cancer hospital (4 of 27 patients [14.8%] vs 8 of 14 patients [57.1%], respectively), and those were directed toward solid tumors and new agents. CONCLUSIONS: Efforts to improve low CCT enrollment among AYAs should be differentiated by treatment site. In the adult setting, these efforts should be aimed at improving CCT availability by overcoming site-level barriers to opening existing CCTs.
BACKGROUND:Low cancer clinical trial (CCT) enrollment may contribute to survival disparities affecting adolescents and young adults (AYAs) (ages 15-39 years). The objective of this study was to evaluate whether differences in CCT availability related to treatment site could explain the low CCT enrollment. METHODS: This prospective, observational cohort study was conducted at an academic children's hospital and its affiliated but geographically separated adult cancer hospital within a National Cancer Institute-designated Comprehensive Cancer Center. For consecutive, newly diagnosed AYA patients, it was determined whether an appropriate CCT existed nationally, was available at the treatment site, and was used for enrollment. Proportions of AYAs in these categories were compared between sites using the chi-square test. RESULTS: One hundred fifty-two consecutive AYA patients were included from the children's hospital (n = 68; ages 15-20 years) and the adult cancer hospital (n = 84; ages 18-39 years). Although there was no difference in CCT existence for individual AYA patients by site (children's hospital [36 of 68 patients; 52.9%] vs adult cancer hospital [45 of 84 patients; 53.6%]; P = .938), CCT availability was significantly lower at the adult cancer hospital (14 of 84 patients [16.7%] vs 30 of 68 [44.1%] at the children's hospital; P < .001). The proportion of AYAs enrolled was low at both sites (8 of 68 patients [11.8%] vs 6 of 84 patients [7.1%], respectively; P = .327). Fewer existing CCTs were available at the adult cancer hospital (4 of 27 patients [14.8%] vs 8 of 14 patients [57.1%], respectively), and those were directed toward solid tumors and new agents. CONCLUSIONS: Efforts to improve low CCT enrollment among AYAs should be differentiated by treatment site. In the adult setting, these efforts should be aimed at improving CCT availability by overcoming site-level barriers to opening existing CCTs.
Keywords:
adolescent; adolescents and young adults (AYAs); clinical oncology; clinical trial as topic; multicenter studies as topic; pediatric oncology; young adult
Authors: Helen M Parsons; Linda C Harlan; Nita L Seibel; Jennifer L Stevens; Theresa H M Keegan Journal: J Clin Oncol Date: 2011-09-19 Impact factor: 44.544
Authors: Stacy D Sanford; Jennifer L Beaumont; Mallory A Snyder; Jennifer Reichek; John M Salsman Journal: Support Care Cancer Date: 2017-01-10 Impact factor: 3.603
Authors: Helen M Parsons; Linda C Harlan; Susanne Schmidt; Theresa H M Keegan; Charles F Lynch; Erin E Kent; Xiao-Cheng Wu; Stephen M Schwartz; Roland L Chu; Gretchen Keel; Ashley Wilder Smith Journal: J Adolesc Young Adult Oncol Date: 2015-09 Impact factor: 2.223
Authors: Hsien-Yeang Seow; Patrick Whelan; Mark N Levine; Kathryn Cowan; Barbara Lysakowski; Brenda Kowaleski; Anne Snider; Rebecca Y Xu; Andrew Arnold Journal: J Clin Oncol Date: 2012-03-26 Impact factor: 44.544
Authors: Nupur Mittal; Anne-Marie Langevin; Wade Kyono; David S Dickens; Allison Grimes; John M Salsman; Brad H Pollock; Michael Roth Journal: J Adolesc Young Adult Oncol Date: 2021-05-13 Impact factor: 2.223
Authors: Elizabeth J Siembida; Holli A Loomans-Kropp; Irene Tami-Maury; David R Freyer; Lillian Sung; Howland E Crosswell; Brad H Pollock; Michael E Roth Journal: Oncologist Date: 2022-05-06 Impact factor: 5.837
Authors: Elizabeth J Siembida; Holli A Loomans-Kropp; Irene Tami-Maury; David R Freyer; Lillian Sung; Howland E Crosswell; Brad H Pollock; Michael E Roth Journal: JNCI Cancer Spectr Date: 2021-03-22
Authors: Elizabeth J Siembida; Holli A Loomans-Kropp; Neha Trivedi; Ann O'Mara; Lillian Sung; Irene Tami-Maury; David R Freyer; Michael Roth Journal: Cancer Date: 2019-12-23 Impact factor: 6.921
Authors: Justine A Ellis; Vajiranee S Malalasekera; Christie Allan; Peter F Choong; Jordan R Hansford; Ryan Hehir; Natasha Morello; Sally O'Callaghan; Lisa Orme; Nitya Phillipson; Mark A Rosenthal; Susan Sawyer; Robyn Strong; Leanne Super; Angela Watt; Chris Williams; Anne Woollett; Alexandra Robertson; Jeremy Lewin Journal: J Adolesc Young Adult Oncol Date: 2021-07-22 Impact factor: 1.757